Medical Subject Headings

Last uploaded: January 16, 2025
Preferred Name

Daclizumab
Synonyms

Zenapax

Ro 247375

Zinbryta

Ro-24-7375

Dacliximab

Ro 24-7375

Ro 24 7375

Definitions

An anti-TAC (INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT) humanized monoclonal antibody (immunoglobulin G1 disulfide with human-mouse monoclonal clone 1H4 light chain, dimer) that is used in the treatment of ACUTE RELAPSING MULTIPLE SCLEROSIS.

ID

http://purl.bioontology.org/ontology/MESH/D000077561

altLabel

Zenapax

Ro 247375

Zinbryta

Ro-24-7375

Dacliximab

Ro 24-7375

Ro 24 7375

AQL

AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR

cui

C0663182

C4257005

C0281549

C0382306

DC

1

definition

An anti-TAC (INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT) humanized monoclonal antibody (immunoglobulin G1 disulfide with human-mouse monoclonal clone 1H4 light chain, dimer) that is used in the treatment of ACUTE RELAPSING MULTIPLE SCLEROSIS.

DX

20190101

HN

2019 (1995)

Inverse of AQ

http://purl.bioontology.org/ontology/MESH/Q000097

http://purl.bioontology.org/ontology/MESH/Q000096

http://purl.bioontology.org/ontology/MESH/Q000627

http://purl.bioontology.org/ontology/MESH/Q000648

http://purl.bioontology.org/ontology/MESH/Q000493

http://purl.bioontology.org/ontology/MESH/Q000494

http://purl.bioontology.org/ontology/MESH/Q000276

http://purl.bioontology.org/ontology/MESH/Q000134

http://purl.bioontology.org/ontology/MESH/Q000266

http://purl.bioontology.org/ontology/MESH/Q000378

http://purl.bioontology.org/ontology/MESH/Q000008

http://purl.bioontology.org/ontology/MESH/Q000009

http://purl.bioontology.org/ontology/MESH/Q000032

http://purl.bioontology.org/ontology/MESH/Q000191

http://purl.bioontology.org/ontology/MESH/Q000302

http://purl.bioontology.org/ontology/MESH/Q000145

http://purl.bioontology.org/ontology/MESH/Q000737

http://purl.bioontology.org/ontology/MESH/Q000502

http://purl.bioontology.org/ontology/MESH/Q000506

http://purl.bioontology.org/ontology/MESH/Q000187

http://purl.bioontology.org/ontology/MESH/Q000235

http://purl.bioontology.org/ontology/MESH/Q000633

http://purl.bioontology.org/ontology/MESH/Q000652

http://purl.bioontology.org/ontology/MESH/Q000528

Inverse of RB

CUJ2MVI71Y

0

isa

http://purl.bioontology.org/ontology/MESH/D007166

LT

TRD

Machine permutation

2019; DACLIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2018; and under ANTIBODIES, MONOCLONAL 1995-2011

Mapped from

http://purl.bioontology.org/ontology/MESH/C000598527

MDA

20180709

MMR

20180409

MN

D12.776.124.486.485.114.224.060.766

D12.776.124.790.651.114.224.060.766

D12.776.377.715.548.114.224.200.766

notation

D000077561

PA

D007166

prefLabel

Daclizumab

RR

152923-56-3 (Daclizumab)

TERMUI

T282705

T000908612

T000940277

T282707

T282706

T000940276

TH

US

UK

NL

NLM (1995)

CA

FDA SRS (2013)

ES

INN (19XX)

USAN (1995)

NLM (2013)

DE

AU

NLM (2017)

FR

tui

T116

T129

T121

subClassOf

http://purl.bioontology.org/ontology/MESH/D061067

Delete Subject Author Type Created
No notes to display
Create mapping

Mapping To Ontology Source
http://purl.bioontology.org/ontology/RXNORM/190353 RXNORM CUI
http://purl.bioontology.org/ontology/PDQ/CDR0000042006 PDQ CUI
http://purl.bioontology.org/ontology/MSHFRE/D000077561 MSHFRE CUI
http://purl.bioontology.org/ontology/NDFRT/N0000148541 NDFRT CUI
http://purl.bioontology.org/ontology/ATC/L04AC01 ATC CUI
http://purl.bioontology.org/ontology/PDQ/CDR0000042006 PDQ CUI
http://purl.bioontology.org/ontology/PDQ/CDR0000042006 PDQ CUI
http://purl.bioontology.org/ontology/MSHFRE/D000077561 MSHFRE CUI
http://purl.bioontology.org/ontology/SCTSPA/109133001 SCTSPA CUI
http://purl.bioontology.org/ontology/NDFRT/N0000005792 NDFRT CUI
http://purl.bioontology.org/ontology/VANDF/4021083 VANDF CUI
http://purl.bioontology.org/ontology/SCTSPA/386977009 SCTSPA CUI
http://purl.bioontology.org/ontology/NDDF/007284 NDDF CUI
http://purl.bioontology.org/ontology/SNOMEDCT/386977009 SNOMEDCT CUI
http://purl.bioontology.org/ontology/SNOMEDCT/109133001 SNOMEDCT CUI
http://purl.bioontology.org/ontology/PDQ/CDR0000042006 PDQ CUI
http://purl.bioontology.org/ontology/RXNORM/190353 RXNORM LOOM
http://purl.obolibrary.org/obo/DRON_00013001 PDRO LOOM
http://purl.obolibrary.org/obo/DRON_00013001 DDSS LOOM
http://purl.obolibrary.org/obo/DRON_00013001 DRON LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000148541 NDFRT LOOM
http://purl.bioontology.org/ontology/ATC/L04AC01 ATC LOOM
http://purl.jp/bio/4/id/200906003374990727 IOBC LOOM
http://purl.bioontology.org/ontology/PDQ/CDR0000042006 PDQ LOOM
http://purl.bioontology.org/ontology/PDQ/CDR0000042006 PDQ LOOM
http://www.drugbank.ca/drugs/DB00111 FTC LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1569 NCIT LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0663182 OCHV LOOM
http://scai.fraunhofer.de/MSOntology#Daclizumab MSO LOOM
http://www.phoc.org.cn/pmo/class/PMO_00026129 PMAPP-PMO LOOM
http://purl.obolibrary.org/obo/NCIT_C1569 BERO LOOM
https://go.drugbank.com/drugs/DB00111 MDM LOOM
http://purl.bioontology.org/ontology/VANDF/4021083 VANDF LOOM
http://purl.obolibrary.org/obo/dinto_DB00111 DINTO LOOM
http://www.co-ode.org/ontologies/galen#Daclizumab GALEN LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#42521 OCHV LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C096001 RH-MESH LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/386977009 SNOMEDCT LOOM